Charles Schwab’s Achieve Life Sciences QUIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.88M Hold
232,138
– – ﹤0.01% 2806
2026
Q2
$1.52M Buy
232,138
+189,138
+440% +$902K ﹤0.01% 2876
2026
Q1
$126K Buy
43,000
+23,000
+115% +$102K ﹤0.01% 3354
2025
Q4
$99.4K Buy
+20,000
New +$87.2K ﹤0.01% 3397
2025
Q2
– Sell
-89,562
Closed -$239K – 3496
2025
Q1
$239K Hold
89,562
– – ﹤0.01% 3236
2024
Q4
$315K Hold
89,562
– – ﹤0.01% 3262
2024
Q3
$425K Sell
89,562
-6,324
-7% -$28.9K ﹤0.01% 3201
2024
Q2
$451K Buy
+95,886
New +$462K ﹤0.01% 3242
2022
Q2
– Sell
-10,306
Closed -$79K – 3538
2022
Q1
$79K Buy
+10,306
New +$76.7K ﹤0.01% 3455
2014
Q2
– Sell
-9
Closed -$230K – 3089
2014
Q1
$230K Hold
9
– – ﹤0.01% 2906
2013
Q4
$163K Hold
9
– – ﹤0.01% 2998
2013
Q3
$179K Hold
9
– – ﹤0.01% 2953
2013
Q2
$190K Buy
+9
New +$201K ﹤0.01% 2921

Other funds holding QUIT

Charles Schwab's QUIT Position: Q3 2026 in Review

Charles Schwab held its Achieve Life Sciences (QUIT) position steady in Q3 2026 at 232,138 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #2806.

Charles Schwab first reported a position in QUIT in Q2 2013 and has held it in 13 quarters since. 132 funds tracked by Wall St. Rank hold QUIT as of Q3 2026.

  • Charles Schwab held 232,138 shares of Achieve Life Sciences worth $1.88M as of Q3 2026.
  • Charles Schwab left its Achieve Life Sciences share count unchanged in Q3 2026.
  • Achieve Life Sciences made up ﹤0.01% of Charles Schwab's portfolio in Q3 2026, its #2806 holding.
  • Charles Schwab first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 13 quarters since.
  • 132 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2026.

Based on Charles Schwab's 13F filing for Q3 2026, filed 16 Nov 2026.